Live Breaking News & Updates on Active Esters

Stay updated with breaking news from Active esters. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Who Should—and Can—Get Lecanemab, the New Alzheimer Disease Drug? | Dementia and Cognitive Impairment | JAMA

This Medical News story examines the complexity of determining who to treat with lecanemab, the new Alzheimer disease drug. ....

United Kingdom , United States , New York , George Perry , Donna Wilcock , Eli Lilly , Russell Swerdlow , James Burke , Sam Grandy , Madhav Thambisetty , Alzeca Bioscience , Robert Howard , Libby Holman , Ivan Cheung , Xavier Becerra , David Knopman , Allison Parks , Bioenergetically Active Esters For Health , Recuerdo Pharmaceuticals , Cure Alzheimer Fund , Alzheimer Network For Treatment , Us Department Of Health , York Stem Cell Foundation , University Of Texas At San Antonio , Translational Neuroscience Section Laboratory Of Behavioral , Centers For Medicare Medicaid Services ,